The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: A multicenter, double-blind, randomized trial

Sarah Tabbutt*, Susan C. Nicolson, Peter C. Adamson, Xuemei Zhang, Marc L. Hoffman, Winfield Wells, Carl L. Backer, Francis X. McGowan, James S. Tweddell, Paula Bokesch, Mark Schreiner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Abstract

Objectives: Blood pressure control is important after repair of coarctation of the aorta. We report the first prospective multi-institutional trial addressing the safety and efficacy of esmolol after repair of coarctation of the aorta in infants and children. Methods: The primary objective of this phase IIIb, multicenter, double-blind, randomized, dose-ranging trial was the efficacy of esmolol to control hypertension. Candidates included subjects younger than 6 years and weighing 2.5 kg or more who underwent surgical intervention for coarctation of the aorta and required therapy for systemic hypertension. One hundred sixteen subjects received esmolol: 36 received a low dose (125 μg/kg), 43 received a medium dose (250 μg/kg), and 37 received a high dose (500 μg/kg). The primary outcomes were the change in systolic blood pressure and the need for additional antihypertensive rescue medication 5 minutes after the initiation of esmolol. Results: All dose groups showed a significant decrease from baseline in systolic blood pressure (-9.6 ± 16.3 mm Hg, P < .001). There were no differences in systolic blood pressure response at 5 minutes between dose groups (high, medium, or low) or age groups. The need for rescue medication at 5 minutes was not different between dose groups. All dose groups showed similar incidences of adverse events. There were no serious adverse events. Discussion: Esmolol can be administered safely to patients younger than 6 years after repair of coarctation of the aorta. In the dose range of 125 to 500 μg/kg, esmolol significantly decreased systolic blood pressure.

Original languageEnglish (US)
Pages (from-to)321-328
Number of pages8
JournalJournal of Thoracic and Cardiovascular Surgery
Volume136
Issue number2
DOIs
StatePublished - Aug 2008

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: A multicenter, double-blind, randomized trial'. Together they form a unique fingerprint.

Cite this